ChromaDex

"We are a global bioscience company dedicated to healthy aging. Our team, which includes world-renowned scientists, is pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. We are the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen®. Nicotinamide riboside and other NAD+ precursors are protected by our patent portfolio. We deliver Niagen® as the sole active ingredient in our consumer product Tru Niagen®. We also have a business unit focused on natural product fine chemicals (known as “phytochemicals”). ChromaDex, Inc. is listed on NASDAQ, stock name CDXC."